ADP provides an experienced and practical approach for guiding life science clients through the R&D tax credit process. Their group of specialized professionals provide the peace of mind that comes with having a highly detailed study outlining qualified research activities and expenses.Continue reading
Author Archive: AZBio
Five Arizona Researchers Make the List of Top1,000 Female Scientists in the World
For the first time, Research.com has published a list of the top 1,000 female scientists in the world.
Congratulations to Barbara Ainsworth, Carol Barnes, Carolyn Compton, Nancy Eisenberg, and Alexandra Navrotsky for this well earned recognition.Continue reading
Arizona Tech Investors Announces New CEO
Bob DeLean to Direct Arizona’s Leading Angel Investing Group’s Next StageContinue reading
AZAdvances is working to support health innovation in Arizona
How You Can Help Advance Health InnovationContinue reading
U.S. Food and Drug Administration approves CSL’s HEMGENIX® (etranacogene dezaparvovec-drlb), the first gene therapy for hemophilia B
- This historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy and generates elevated and sustained factor IX levels for years after a one-time infusion
- With the approval of HEMGENIX, CSL now offers an even more comprehensive portfolio of treatments for people living with hemophilia B, ushering in a new era of treatment options
Student Opportunity – 2023 KEYS Internships
The 2023 KEYS Research Internship applications opened November 21, 2022.Continue reading
Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer
PHOENIX, Arizona and OSLO, Norway — November 21, 2022 — Scientists at the Phoenix-based Translational Genomics Research Institute (TGen), part of City of Hope, and EXACT Therapeutics AS (“EXACT-Tx”, Euronext Growth: EXTX), a Norwegian clinical stage precision health company, today report that the ultrasound based Acoustic Cluster Therapy (ACT®) significantly enhanced the antitumor efficacy of standard care therapies in a preclinical model for pancreatic cancer.Continue reading
Five Leaders Elected to the AZBio Board of Directors
Tony Caldwell of Snell & Wilmer, Brandy Flores of Pfizer, Renée Galá of Jazz Pharmaceuticals, Shannon Groppenbacher of Johnson & Johnson, and Nathan Trembath of Bristol Myers Squibb, join the Arizona Bioindustry Association leadership team.Continue reading
New State of Arizona Web Portal Makes It Easier to Launch a Business in Arizona
Newly streamlined Arizona Business One Stop process makes it easy to plan, start and grow a business in the stateContinue reading
FDA Approves First and Only Treatment Indicated to Delay the Onset of Stage 3 Type 1 Diabetes
TZIELD™ (teplizumab-mzwv) approved by FDA as the first and only treatment indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients aged 8 years and older with Stage 2 T1D